Ohno's "peril of hemizygosity" revisited: gene loss, dosage compensation, and mutation. (41/55)

 (+info)

Genotype-phenotype correlation in 22q11.2 deletion syndrome. (42/55)

 (+info)

Modeling and rescue of the vascular phenotype of Williams-Beuren syndrome in patient induced pluripotent stem cells. (43/55)

 (+info)

Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma. (44/55)

 (+info)

Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes. (45/55)

 (+info)

Precise breakpoint localization of large genomic deletions using PacBio and Illumina next-generation sequencers. (46/55)

 (+info)

Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation. (47/55)

 (+info)

Gene expression patterns of hemizygous and heterozygous KIT mutations suggest distinct oncogenic pathways: a study in NIH3T3 cell lines and GIST samples. (48/55)

 (+info)